DekaBank Deutsche Girozentrale - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 189 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$1,627,000
+111.8%
24,2500.0%0.01%
+150.0%
Q2 2022$768,000
-9.4%
24,2500.0%0.00%0.0%
Q1 2022$848,000
+28.7%
24,250
+10.0%
0.00%0.0%
Q4 2021$659,000
+20.3%
22,050
+2.8%
0.00%0.0%
Q3 2021$548,000
-20.1%
21,4500.0%0.00%0.0%
Q2 2021$686,000
-20.6%
21,4500.0%0.00%
-33.3%
Q1 2021$864,000
-7.9%
21,4500.0%0.00%
-25.0%
Q4 2020$938,000
-21.8%
21,450
-4.9%
0.00%
-20.0%
Q3 2020$1,200,000
-22.3%
22,550
-21.2%
0.01%
-37.5%
Q2 2019$1,544,000
+80.0%
28,600
+63.4%
0.01%
+60.0%
Q1 2019$858,000
+50.3%
17,500
+22.4%
0.01%
+25.0%
Q4 2018$571,000
-33.4%
14,300
-18.3%
0.00%
-20.0%
Q3 2018$858,000
+0.5%
17,500
-2.8%
0.01%
-16.7%
Q2 2018$854,000
-0.6%
18,0000.0%0.01%0.0%
Q1 2018$859,000
+305.2%
18,000
+143.2%
0.01%
+200.0%
Q4 2017$212,0000.0%7,4000.0%0.00%0.0%
Q3 2017$212,000
+0.5%
7,4000.0%0.00%0.0%
Q2 2017$211,0007,4000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2021
NameSharesValueWeighting ↓
Logos Global Management LP 850,000$46,869,0006.00%
Asymmetry Capital Management, L.P. 155,232$8,559,0005.50%
Grace Capital 124,749$6,878,0005.33%
Fernwood Investment Management, LLC 187,477$10,337,0004.88%
Perceptive Advisors 5,800,996$319,867,0004.67%
ArchPoint Investors 217,510$11,993,0003.83%
GREAT POINT PARTNERS LLC 655,676$36,154,0003.25%
Profit Investment Management, LLC 42,196$2,328,0001.44%
Bain Capital Public Equity Management II, LLC 381,868$21,056,0001.39%
Taylor Wealth Management Partners 52,597$2,900,0001.33%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders